AblationforCardiacArrhythmias near Bronx, NY

Biography: Dr. Evelyn Horn is the Director of the Perkin Heart Failure Center of Weill Cornell, specializing in Heart Failure, Pulmonary Hypertension, and Mechanical Circulatory Support.Patients referred to the Center include those with diagnoses of systolic heart failure, valvular heart disease, preserved EF heart failure; pulmonary vascular disease - idiopathic, associated and secondary.Evelyn M. Horn, M.D. is a graduate of Brown University, Mount Sinai Medical School where she also was a medical intern and resident. She completed cardiology at the Cedars Sinai/UCLA program and thereafter spent 2 years as a research fellow at Columbia College of Physicians and Surgeons understanding the beta adrenergic G protein complex in heart failure, the denervated heart and models of arrhythmias. She remained at Columbia University Medical Center in the Divisions of Circulatory Physiology and Cardiology Center for Advanced Cardiac Care where she was at various times, Director of the Circulatory Physiology fellowship program, Director of Clinical Services for Heart Failure, Associate Director of the combined Pediatric & Adult Pulmonary Hypertension Center and Director of the Pulmonary Vascular program of the Center for Advanced Cardiac Care. She also was the director of the High Risk Cardiac Obstetrical program. She received numerous awards as clinician educator, continues to participate in clinical research in the areas of cardiac and vascular remodeling in heart failure and pulmonary hypertension.The Heart Failure program provides management of advanced heart failure (both systolic and diastolic), congenital heart disease, perioperative management of conventional cardiac surgical patients (high risk patients and high risk valve surgery), and ventricular assist devices. The center also offers rare expertise in the management of pulmonary hypertension, including idiopathic pulmonary hypertension and pulmonary hypertension associated with diseases such as connective tissue disease, congenital heart disease as well as a huge number of patients who have it in association with left heart disease and others have it associated with lung disease, certain hematological diseases or liver disease. Pulmonary hypertension and right heart failure complicates the management of about 1/3 of the patients with heart failure. In many, right heart failure follows left heart failure but management of difficult "cases" may require a special expertise and understanding of the interdependence of the right and the left ventricles. If cases become complicated by secondary pulmonary hypertension or right heart failure, most of Dr. Horn's colleagues seek out the "right heart doctor," as she has sometimes been called or the combined left and right heart doc.The phenotype of heart failure has multiple etiologies, and not all heart failure behaves the same way. Because of the nuances and subtleties involved in advanced heart failure, she stresses the importance of the multidisciplinary, collaborative center. Moreover, Dr. Horn points to the center's expertise in identifying the appropriateness and the optimal timing of therapeutic interventions. "We have fantastic technologies and therapies available, but these may not be in every patient's best interest," she explains. "It is essential to understand when therapies will or will not work, and when one has to move beyond them, perhaps to mechanical assist devices or heart transplantation for heart failure and lung transplantation for pulmonary hypertension. If we wait too long, we may have missed the opportunity to treat a patient, but no one wants to resort to devices or transplantation before a patient absolutely needs it."Dr. Horn's clinical research interests have been in ventricular and vascular remodeling in pulmonary hypertension and heart failure. Specific areas have included RV imaging, pulmonary hypertension outcome studies, use of vasopressin in pulmonary hypertension, endothelial dysfunction in pulmonary hypertension, RV dysfunction in the perioperative patient population, complications of pulmonary hypertension therapy, and assessment of the non PAH pulmonary hypertension patient population. She has been actively involved in the care of patients with valvular heart disease and in particular comorbidities of ventricular dysfunction and/or pulmonary vascular disease. She has been actively involved in the care of patients needing ventricular assist device therapies as a bridging or destination device. Along with colleagues, she has authored papers in the field of newer therapies for pulmonary hypertension, epidemiological assessments of patients with pulmonary hypertension, genetics of pulmonary hypertension, and markers of vascular dysfunction. She has been involved in industry sponsored heart failure and pulmonary hypertension studies, industry sponsored investigator initiated studies and collaborative NIH studies in Heart Failure and Pulmonary Hypertension. She has also been the liaison to high risk cardiac OB programs for the care of the complicated cardiac OB patient.Research and invited lectures have been presented at major National and International meetings. She is a fellow of the International Pulmonary Vascular Research Institute, helping to establish ISLHT Pulmonary Hypertension Committee and has been the recipient of teaching awards at Columbia University. Dr. Horn has created a NY Pulmonary Hypertension consortium, a network of a dozen specialists from the tri-state area, to encourage ongoing collaborative studies in pulmonary hypertension.

Biography: Dr. Johanna Contreras, MD is a Clinical Cardiac Electrophysiologist who practices in New York, NY. She is 50 years old and has been practicing for 27 years. Dr. Johanna Contreras, MD is affiliated with Mount Sinai Hospital and Mount Sinai Morningside.

Biography: Dr. Douglas Distefano, MD is a Cardiology Specialist who practices in New York, NY. He is 77 years old and has been practicing for 51 years. Dr. Douglas Distefano, MD is affiliated with Mount Sinai Hospital.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.

Biography: Dr. Prakash Krishnan, MD is an Interventional Cardiology Specialist who practices in New York, NY. He is 57 years old and has been practicing for 28 years. Dr. Prakash Krishnan, MD is affiliated with Mount Sinai Hospital and Mount Sinai Morningside.

Biography: Dr. Vishal Kapur, MD is a Cardiology Specialist who practices in New York, NY. He is 48 years old and has been practicing for 24 years. Dr. Vishal Kapur, MD is affiliated with Mount Sinai Hospital and Mount Sinai Morningside.

Biography: Dr. Nitin Barman, MD is a Cardiology Specialist who practices in New York, NY. He is 51 years old and has been practicing for 26 years. Dr. Nitin Barman, MD is affiliated with Mount Sinai Hospital.

Biography: Dr. Laighold was born and raised in New York City and attended high school near Weill Cornell. Dr. Laighold graduated with honors from the University of Michigan, and then attended Weill Medical College of Cornell University. He completed his residency in internal medicine at Thomas Jefferson University Hospital in 2006 and his fellowship in cardiology at North Shore University Hospital/LIJ Medical Center in 2009.Dr. Laighold joined the faculty in 2024 from Northwell Health where he had worked since 2009. He previously was the Director of Clinical Cardiology at Southside Hospital and the Director of Noninvasive Structural Heart Program at North Shore University Hospital.

Biography: Dr. McDonald graduated from New York University with a bachelor's degree in biology. He received his medical degree from the New York University School of Medicine. Dr. McDonald remained at NYU after graduating from medical school to complete his internal medicine residency training there. He then completed fellowships in cardiovascular disease and advanced heart failure and transplant cardiology at New York Presbyterian/Weill Cornell Medical Center.

Biography: Dr. Daniel Lu graduated from Brown University with a Bachelor of Science in Biochemistry and Molecular Biology. He then completed his medical training as well as a Masters of Health Sciences at Yale School of Medicine, followed by internship and residency in Internal Medicine at the Hospital of the University of Pennsylvania. He then completed his subspecialty training in Cardiology at New York-Presbyterian Hospital - Weill Cornell Medical Center, and underwent further subspecialty training in Advanced Heart Failure and Transplant Cardiology at both NYP-Cornell and NYP-Columbia. Dr. Lu has co-authored numerous research papers in medicine and cardiology and maintains an active research interest investigating outcomes of treatment for heart failure and cardiogenic shock.

Biography: Dr. Homan completed his fellowship in Cardiovascular Disease at NewYork-Presbyterian/Cornell, where he served as Chief Cardiology Fellow and undertook an additional year of laboratory training in cardiometabolic biology with Dr. James Lo. He completed his Internal Medicine residency at NewYork-Presbyterian/Columbia, before which he received his M.D. degree from the Icahn School of Medicine at Mount Sinai. Prior to medical school he earned a Ph.D. in Chemistry from Harvard University and received his B.S. degree in Chemistry from the University of Florida in Gainesville.Dr. Homan's research has focused on understanding the relationship between obesity and cardiovascular disease. During his cardiology fellowship at Weill Cornell, he studied the role of the innate immune system in obesity-related liver disease and heart failure, and he received the Glorney-Raisbeck Fellowship Award in Cardiovascular Disease. In his PhD research at Harvard University, he discovered a new class of endogenous lipid molecules that he named fatty acyl hydroxy fatty acids (FAHFAs), which were ultimately found to have anti-diabetic and anti-inflammatory properties.Dr. Homan is a fellow of the American College of Cardiology, a diplomate of the American Board of Clinical Lipidology and a member of the National Lipid Association, and member of the American Society of Echocardiography. He also speaks Spanish and French.

Biography: Dr. Feldman is an Assistant Professor of Medicine in the Division of Cardiology of the Department of Medicine at Weill Cornell Medical College and an Attending Physician at New York Presbyterian-Weill Cornell Medical Center.Dr. Feldman grew up in Framingham, Massachusetts and completed her undergraduate studies at the University of Pennsylvania. She earned her medical degree from Boston University School of Medicine, completed Internal Medicine residency at Beth Israel Deaconess Medical Center/Harvard Medical School, where she completed the Clinician Educator Track, fellowship in Cardiovascular Disease at Boston Medical Center/Boston University School of Medicine, and an additional fellowship in Cardio-Oncology at Memorial Sloan Kettering Cancer Center. After training, she founded and directed the Cardio-Oncology and Cardiac Amyloidosis programs at Rutgers New Jersey Medical School/University Hospital. In 2023, she joined the Cardiology Division at New York-Presbyterian/Weill Cornell Medical College as a full-time faculty member where she provides expertise in cardio-oncology, cardiac imaging, and medical education. She serves as the Director of the Cardio-Oncology program.Dr. Feldman is board certified in Internal Medicine, Cardiovascular Diseases, Echocardiography, Nuclear Cardiology, and Cardio-Oncology. She is a fellow of the American College of Cardiology, and a member of the American Heart Association, American Society of Nuclear Cardiology, and the International Society of Cardio-Oncology.

Biography: An international leader in pediatric cardiology, Christopher J. Petit, MD, has particular expertise in minimally invasive techniques to treat valve disease and complex congenital heart disease. Recognized for his clinical innovations, development of specialty programs, and his research accomplishments, Dr. Petit believes that the field of pediatric cardiology advances through collaborative discovery. He has been an active clinician-scientist, working to determine the best treatments for patients with congenital heart disease. Dr. Petit founded and currently serves as President of the Congenital Cardiac Research Collaborative.

Biography: Dr. Gabriel Sayer is the Associate Director of Advanced Heart Failure, Cardiac Transplantation and Mechanical Circulatory support at NewYork-Presbyterian. In this role, Dr. Sayer provides leadership and oversight for the comprehensive heart failure services provided across NewYork-Presbyterian, including the campuses in Manhattan, Queens, Brooklyn and Westchester. Dr. Sayer attended medical school at the University of Pennsylvania, followed by Internal Medicine residency at Columbia University Irving Medical Center. He completed Cardiology fellowship at Mount Sinai Medical Center and his Advanced Heart Failure fellowship at Massachusetts General Hospital. Prior to joining NewYork-Presbyterian in 2019, Dr. Sayer worked at the University of Chicago for six years, where he was the Associate Director of the Heart Failure, Mechanical Circulatory Support and Cardiac Transplantation programs. In addition to his extensive clinical experience in all aspects of heart failure, Dr. Sayer has published nearly 100 peer-reviewed articles in the field of advanced heart failure. His research interests include the impact of of heart failure treatments on cardiac physiology, with a particular interest in the interaction between patients and mechanical circulatory support devices. https://youtu.be/vT5s8orP6V8

Biography: Dr. Noa Zemer Wassercug is a board-certified cardiologist with expertise in adult congenital heart disease. She is an assistant professor of medicine at Columbia University Irving Medical Center (CUIMC) and an assistant attending cardiologist at NewYork-Presbyterian Hospital (NYP). Dr. Zemer Wassercug's clinical expertise is focused on adult congenital heart echocardiography and pregnancy management in women with congenital heart disease. She is an attending physician at Columbia's Schneeweiss Adult Congenital Heart Center. Dr. Zemer Wassercug received her Doctor of Medicine from the Sackler School of Medicine at Tel Aviv University. She completed a cardiology fellowship at Rabin Medical Center, followed by a fellowship in adult congenital heart disease at NYP/CUIMC. She sees patients in Washington Heights in Manhattan.

Biography: Michael B. Collins, MD is an Interventional Cardiologist at Columbia Interventional Cardiovascular Care, the Associate Director of the Cardiovascular Catheterization Lab at Columbia University Irving Medical Center/NewYork-Presbyterian Hospital and Professor of Medicine at Columbia University College of Physicians and Surgeons. Dr. Collins specializes in complex percutaneous coronary interventions. Dr. Collins received his medical degree in 1975 from Yale University School of Medicine, New Haven, Connecticut.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience We are devoted to providing services that are patient centered and compassionate and care for you as a person nbsp;